Photosensitizing medication and sun protection: what the clinical sources actually ask for

Photosensitizing Medication and Sun: What the Labels Actually Say

Somebody hands you a pharmacy leaflet, you get as far as the line about sun sensitivity, and then the leaflet stops being useful. It tells you a reaction can happen. It doesn’t tell you what to change on a Tuesday in July. That gap is the entire reason this page exists, and we’re going to stay on our side of it: we don’t touch what’s in the bottle, only what goes on your skin. If you’re taking a photosensitizing medication, the sun part is the part you actually control.

The short version: DermNet describes this as “a common adverse drug reaction resulting in a cutaneous eruption after exposure to visible or ultraviolet (UV) radiation in patients taking topical or systemic photosensitising medications.” [1] The sun-side instruction is short and boring: “high SPF broad-spectrum sunscreen with good UVA protection, sun protective clothing, eye protection, and avoiding sun exposure during peak ultraviolet index times.” [1] One FDA label goes as far as naming our subject out loud: “Sunscreen or sunblock should be considered.” [4] Everything about the drug itself belongs to whoever prescribed it. This is a sunscreen blog, and nothing on this page is a reason to change how you take anything.

What a photosensitizing medication actually is

It’s a drug that absorbs light once it’s in your skin, which then sets off a skin reaction. That’s the whole mechanism, and DermNet writes it in one line: “The drug or its metabolites present within the skin absorbs UV radiation and triggers a chemical photosensitivity reaction, either phototoxic (more common) or photoallergic.” [1]

Two things follow from that, and they’re the useful ones.

  • It’s about light, not heat. The 2021 review we read notes that the UV reaching your skin is “approximately 5% UVB and 95% UVA,” and that visible wavelengths “show deep skin penetrance and can influence structures in the epidermis, dermis, and subcutis.” [2] That’s why DermNet’s sunscreen line specifies UVA protection rather than just a big SPF number. If you’ve never worked out what the UVA half of a Korean label means, we took it apart in our PA rating guide.
  • The sun isn’t the only source. The same review points out that “apart from sunlight, there are other sources of UV radiation that can induce photosensitivity reactions,” and names “specialized lamps used in phototherapy and dental care as well as tanning beds used in solariums.” [2]

How common is it? DermNet gives one number, and we’re going to quote the hedge with it because the hedge is half the sentence: “DIP is generally considered to account for up to 8% of reported adverse cutaneous reactions to drugs, although it is likely underdiagnosed and underreported.” [1] Read the denominator slowly. That’s a share of reported skin reactions to drugs. It is not your odds of reacting to something you’re taking. The review does carry per-drug percentages, but each one is quoted from a paper it cites rather than measured in the review itself, and we couldn’t open those papers to check who was counted or how, so we’ve left those numbers out entirely. [2]

Two reaction types, and why we won’t help you tell them apart

The literature splits these into two, and the split is real. Sorting your own skin into one of the two boxes is a different job, and it isn’t ours.

Phototoxic, as the literature describes itPhotoallergic, as the literature describes it
Timing “Develops within minutes to hours” [1] “Develops within 24 to 72 hours” [1], after a first sensitization period, of which DermNet says “The initial sensitisation period typically takes 7–10 days.” [1]
What the skin looks like “Affected skin resembles an exaggerated sunburn-type reaction” [1] “Affected skin resembles an eczematous eruption” [1]
Mechanism Described as “a non-immunologic cutaneous reaction” [1] Described as “an immune-mediated delayed type IV hypersensitivity reaction” [1]
Usual route “Phototoxicity is often caused by systemic drugs while photoallergy is typically caused by topical agents.” [1] DermNet also says flatly that “Phototoxic reactions are more common than photoallergic reactions.” [1]

Now the part that keeps us honest. That table is a description of two categories in a dermatology reference. It is not a checklist for deciding which one you have. DermNet puts the actual answer in the diagnosis section, where the investigations listed are phototesting, photopatch testing, and rarely a skin biopsy. [1] Those are clinic procedures. A blog post can tell you the categories exist. It cannot look at your arm.

Whose list this is

Short answer: not ours. Every drug name below is printed in a source we opened, and we’ve said which one for each row. We haven’t added a single name of our own.

The 2021 review sets the scale first: the risk “concerns several hundred currently used drugs,” and it adds that medicines are a large share of photosensitizing substances “including those available without a prescription (OTC).” [2] So this isn’t a short list, and it isn’t only a prescription list.

ClassNames printed in the sourceSource
AntibioticsFluoroquinolones (ciprofloxacin), tetracyclines (doxycycline) and sulfonamides in the phototoxic column; fluoroquinolones and dapsone in the photoallergic oneDermNet, Table 1 [1]
AntifungalsGriseofulvin, itraconazole, ketoconazole, voriconazole as phototoxic; griseofulvin also as photoallergicDermNet, Table 1 [1]
Heart and blood pressure drugs, diureticsAmiodarone, atorvastatin, diltiazem, furosemide, hydrochlorothiazide, quinidine as phototoxic; quinidine and hydrochlorothiazide also as photoallergicDermNet, Table 1 [1]
Anti-inflammatory painkillersIbuprofen, naproxen, piroxicam, diclofenac, ketoprofen, celecoxib as phototoxic; ketoprofen, piroxicam, diclofenac and etofenamate as photoallergicDermNet, Table 1 [1]
PsoralensMethoxsalen, 5-methoxypsoralen, trioxsalen, and topical psoralensDermNet, Table 1 [1]
OthersBRAF inhibitors (vemurafenib), oral retinoids (acitretin, isotretinoin), phenothiazines (chlorpromazine, promethazine), St John’s wort, sulfonylureas (glipizide), fluorouracil cream, coal tar, topical retinoids, pyridoxine, quinineDermNet, Table 1 [1]
Named by the AAD’s summer skin pageKetoprofen, described there as found in some pain meds, plus tetracycline, doxycycline and minocyclineAAD, sun allergy section [3]

We left one row of DermNet’s table out of ours, the photodynamic therapy agents such as methyl aminolevulinate, since those are given to you in a clinic rather than taken at home.

One more from the review, because it’s a ranking rather than a rate and we can quote it as written: “phototoxic reactions occur most frequently with the use of demeclocycline, considered the strongest photosensitizer in this group, and doxycycline.” [2]

Being on a list like this is not a diagnosis and it isn’t a verdict on your prescription. The list is a reason to be deliberate about sun protection, which is the only thing we’re qualified to talk about.

Worth separating out, since our other guides live next door: this page is about medicines, and swallowing them isn’t the dividing line. DermNet’s table lists topical medicines in both of its columns, and it says outright that “Phototoxicity is often caused by systemic drugs while photoallergy is typically caused by topical agents.” [1] What this page isn’t about is the cosmetic actives in a skincare routine. If your question is really about a retinoid or an acid in your routine, those have their own rules and their own evidence, and we wrote them up in retinol and sunscreen and AHA, BHA and sunscreen. If you’re recovering from a laser or a peel, that’s a third situation again, covered in sunscreen after cosmetic procedures.

I’m on one of these. What do I actually do about the sun?

Four things, and all four come straight out of the sources rather than from us.

  1. Find out first, and ask the right person. The AAD’s instruction is refreshingly unglamorous: “Check your medication container (or ask your pharmacist) to find out if it can cause an allergic reaction when you go out in the sun.” [3] Your pharmacist has the label in front of them and we don’t. That same AAD bullet ends with a second instruction, and this one we are carrying over word for word rather than leaving it in the sources: “If the medicine can cause a reaction, stay out of the sun.” [3] We’re repeating it because it’s about the sun rather than about the prescription, which puts it on our side of the line, unlike the sentences we’ve left in the footnotes. In the AAD’s own bullets it comes before the one about shade, clothes and sunscreen.
  2. Sunscreen, with the UVA half specified. DermNet’s general measures start with “high SPF broad-spectrum sunscreen with good UVA protection.” [1] The AAD’s version of the same instruction puts numbers on it: “applying sunscreen that offers broad-spectrum protection, water resistance, and an SPF of 30 or more.” [3] Neither of them asks for a filter type, and neither asks for a special product. If reapplying is where your routine falls apart, that’s covered in our reapplication guide.
  3. Clothing and shade, treated as equals rather than backup. DermNet lists “sun protective clothing” and “eye protection” in the same breath as the sunscreen. [1] The AAD says “seeking shade, wearing sun-protective clothes.” [3] We took apart what a fabric rating does and doesn’t promise in our UPF clothing guide.
  4. Time of day, using an actual number. DermNet’s phrasing is “avoiding sun exposure during peak ultraviolet index times.” [1] The UV index is a published forecast for your location, not a vibe, and we explained how to read it in our UV index guide.

One doxycycline label is where sunscreen turns up inside a regulated document. The one we opened is a delayed-release tablet from Actavis Pharma, and its patient counseling section tells prescribers to advise patients “to avoid excessive sunlight or artificial ultraviolet light while receiving doxycycline,” and the same bullet ends with “Sunscreen or sunblock should be considered.” [4] There’s a clause in the middle of that bullet about the treatment itself. It’s addressed to a prescriber, it concerns a decision we have no standing in, and we’ve left it in the sources list rather than restating it as though a sunscreen blog were the right place to read it.

Labels vary a lot in how much they say, including between manufacturers of the same drug. The one hydrochlorothiazide label we opened, a capsule from a repackager called RemedyRepack, lists photosensitivity among its adverse reactions and carries no sun protection wording at all. [5] That’s a fact about two specific documents out of a great many: querying DailyMed’s listing service by drug name on 29 July 2026 returned 385 records for doxycycline and 789 for hydrochlorothiazide. [4] [5] So this doesn’t rank the two drugs, and a quiet label is not evidence of anything either way. The one worth reading is the leaflet that came in your box.

Is my sunscreen enough on its own?

Nothing we read tested that, so we can’t tell you yes and we won’t tell you no.

Here’s what we can tell you about the shape of the evidence. Every source that gives sun advice here gives it as a bundle. DermNet’s general measures put sunscreen, clothing, eye protection and timing in one sentence. [1] The AAD’s prevention bullets pair shade and clothing with the sunscreen. [3] The doxycycline label pairs “avoid excessive sunlight” with the sunscreen line rather than offering the sunscreen as a substitute. [4] None of the three presents a bottle as the whole answer, and none of them ran a trial comparing sunscreen alone against sunscreen plus covering up in people taking these drugs. We went looking for that trial and came up empty.

The 2021 review is worth being explicit about here, because we’d rather show you what it isn’t. It’s a chemistry and cell biology review. In the body of the paper the word sunscreen appears exactly once, in that cross-sensitivity note, and the paper carries no photoprotection recommendations at all. [2] That’s a fact about what the paper set out to do. It’s not an argument that sunscreen doesn’t help, and we’re not going to let it become one.

DermNet does say one thing about living with this long term that lands on our side of the line: “In cases when discontinuing the medication is not an option, symptom control with strict sun protection can effectively manage DIP symptoms.” [1] Note which branch that sentence belongs to. Whether the medication continues is somebody else’s call. What that sentence says about our half is that the sun protection is expected to be strict, not casual.

Sunscreen ingredients are on that list too

This is the part we’d be embarrassed to leave out of a sunscreen blog, so here it is.

DermNet’s photoallergic column includes an entry reading “Topical sunscreen agents (eg, benzophones),” alongside fragrances, which it gives as musk ambrette and 6-methylcoumarin, and wound cleansers such as chlorhexidine and hexachlorophene. [1] The 2021 review adds a specific pairing: ketoprofen “is the most frequent cause of photoallergy due to topical NSAIDs,” and there were “demonstrated cross-sensitivity reactions between ketoprofen and tiaprofenic acid, ibuprofen, suprofen, fenofibrate, and sunscreens containing oxybenzone.” [2]

What that does and doesn’t mean, carefully. It means a class of UV filters and a class of fragrance ingredients appear on a published photoallergen list. It does not mean your sunscreen is going to cause a reaction, and it is nowhere near a reason to stop wearing sunscreen. Both sources that give sun advice on this topic ask for sunscreen by name. [1] [3] If you want the plain-language version of which filters are which, we wrote a filter explainer, and if the fragrance line above is the one that caught your eye, our fragrance-free picks are sorted by what the ingredient lists actually say.

Where this page stops

It stops at your skin. We can read labels and quote dermatology references, and that’s the whole of what we do here.

Everything about the drug itself belongs to the person who prescribed it and the pharmacist who filled it. They know why you’re taking it, what it’s doing for you, and what the alternatives cost. We know none of that, and no page that hasn’t met you should be nudging you about it. If anything either of them tells you contradicts what you read here, go with them and not with us.

The one thing we’d hand you on the way out is smaller than it sounds: sun protection here is a set of four habits rather than one purchase. Sunscreen with real UVA coverage, clothes, shade, and paying attention to the time of day. That’s what the sources ask for, and it’s the same set they’d ask for anyway. Being on a list like this is a reason to do all four properly rather than casually.

FAQ

How do I find out whether what I’m taking is a photosensitizing medication?

Ask the person who can see the label. The AAD’s instruction is to “Check your medication container (or ask your pharmacist) to find out if it can cause an allergic reaction when you go out in the sun.” Your pharmacist can do that in under a minute and has the actual product in front of them. A dermatology reference like DermNet lists drug classes, which is useful for orientation, but a class list can’t confirm what’s in your specific box.

Should I stop my medication over the summer?

That question isn’t ours to answer, and we’re not going to answer it sideways either. We don’t know why you’re taking it or what it’s doing for you, and a sunscreen blog is the wrong place to weigh that. Take it to the prescriber or the pharmacist. What we can say is that DermNet’s own text covers the case where a medication continues, and describes strict sun protection as the way symptoms get managed in that situation.

Do I need a higher SPF than everyone else?

Neither source we read gives a separate number for people on these drugs. DermNet asks for “high SPF broad-spectrum sunscreen with good UVA protection,” and the AAD asks for “broad-spectrum protection, water resistance, and an SPF of 30 or more.” The word that repeats in both is broad-spectrum, and the UVA half is what DermNet specifies rather than the SPF figure, which is worth noticing since the UV reaching your skin is roughly 95% UVA.

How fast would I even notice something?

The literature describes two different timelines, and it describes them for the two reaction types rather than for individual people. DermNet’s table gives phototoxic reactions as developing within minutes to hours, with skin that resembles an exaggerated sunburn. Photoallergic ones are given as developing within 24 to 72 hours, resembling eczema instead, and following a first sensitization period the page puts at 7 to 10 days. That’s a textbook description of two categories, not a way to classify your own skin. Sorting an actual rash into one of those boxes takes phototesting or photopatch testing, which happens in a clinic.

Could my sunscreen itself be part of the problem?

It’s on the list, which is a smaller statement than it sounds. DermNet’s photoallergic column includes “Topical sunscreen agents (eg, benzophones)” and fragrances such as musk ambrette and 6-methylcoumarin, and the 2021 review records cross-sensitivity between ketoprofen and “sunscreens containing oxybenzone.” Appearing on a photoallergen list is not the same as predicting a reaction to your bottle, and both sources that give sun advice on this topic still ask for sunscreen by name.

Sources

Clinical references, each page opened in full on 2026-07-29. No named clinician is quoted anywhere on this page. Every quotation below is from a page’s or paper’s own text:
[1] Drug-induced photosensitivity, DermNet. Last reviewed April 2023; authors Dr Lachlan Dat Wah Lau, Dr Mi Vu and A/Prof Laura Scardamaglia, Melbourne, Australia; reviewing dermatologist Dr Ian Coulson. Quoted from the page’s own text: “Drug-induced photosensitivity (DIP) is a common adverse drug reaction resulting in a cutaneous eruption after exposure to visible or ultraviolet (UV) radiation in patients taking topical or systemic photosensitising medications.”; “The drug or its metabolites present within the skin absorbs UV radiation and triggers a chemical photosensitivity reaction, either phototoxic (more common) or photoallergic.”; “DIP is generally considered to account for up to 8% of reported adverse cutaneous reactions to drugs, although it is likely underdiagnosed and underreported.”; “Phototoxic reactions are more common than photoallergic reactions.”; “a non-immunologic cutaneous reaction”; “an immune-mediated delayed type IV hypersensitivity reaction”; “The initial sensitisation period typically takes 7–10 days.”; Table 2 rows “Develops within minutes to hours” / “Develops within 24 to 72 hours” / “Affected skin resembles an exaggerated sunburn-type reaction” / “Affected skin resembles an eczematous eruption”; Table 3 row “Phototoxicity is often caused by systemic drugs while photoallergy is typically caused by topical agents.”; general measures “Photoprotective measures such as high SPF broad-spectrum sunscreen with good UVA protection, sun protective clothing, eye protection, and avoiding sun exposure during peak ultraviolet index times.”; outcome “In cases when discontinuing the medication is not an option, symptom control with strict sun protection can effectively manage DIP symptoms.” All drug names in our class table are taken from this page’s Table 1, “Common photosensitising agents”, which prints two columns, phototoxic and photoallergic; the sunscreen entry appears in the photoallergic column exactly as “Topical sunscreen agents (eg, benzophones)”, which we have reproduced as printed. The page also carries a treatment section and a prevention section written for clinicians, including the sentences “Identify and cease the suspected photosensitising medication.” and “Discontinuing the photosensitising medication and sun protection remain the mainstay preventative measures for DIP.” We recorded them here for completeness and deliberately did not carry them into the article, because decisions about a prescription are not something this site is in a position to advise on. Note that this page uses British spellings. link
[2] Kowalska J, Rok J, Rzepka Z, Wrześniok D. Drug-Induced Photosensitivity: From Light and Chemistry to Biological Reactions and Clinical Symptoms. Pharmaceuticals (Basel). 2021;14(8):723. Full text read via PubMed Central, PMC8401619. The journal prints a long dash where we have written a colon in that title, and we have not put the title in quotation marks for that reason. Quoted from the paper’s own text: “The risk of phototoxic and photoallergic reactions concerns several hundred currently used drugs”; “including those available without a prescription (OTC)”; “UV radiation reaching the skin’s surface comprises approximately 5% UVB and 95% UVA”; “Visible wavelengths show deep skin penetrance and can influence structures in the epidermis, dermis, and subcutis”; “apart from sunlight, there are other sources of UV radiation that can induce photosensitivity reactions”; “specialized lamps used in phototherapy and dental care as well as tanning beds used in solariums”; “It has been found that phototoxic reactions occur most frequently with the use of demeclocycline, considered the strongest photosensitizer in this group, and doxycycline”; “Ketoprofen is the most frequent cause of photoallergy due to topical NSAIDs”; “There were demonstrated cross-sensitivity reactions between ketoprofen and tiaprofenic acid, ibuprofen, suprofen, fenofibrate, and sunscreens containing oxybenzone.” Numbers we chose not to use: this review reports per-drug percentages for doxycycline, demeclocycline, amiodarone and thiazide diuretics, but each is attributed to an earlier paper it cites rather than measured in the review, and we were not able to open those cited papers to check the populations or study designs, so none of those figures appears on this page. This review is a chemistry and cell biology paper; it contains no photoprotection or sunscreen recommendations, which is a statement about its scope and not an argument about whether sunscreen helps. Counted by hand: “sunscreen” occurs once in the body of the paper, in the cross-sensitivity sentence quoted above, and once more in the title of a 1997 paper in its reference list, which we did not open or use. link
[3] 12 summer skin problems you can prevent, American Academy of Dermatology, sun allergy section. Scope note, because it matters: we could not find a dedicated AAD public page on drug-induced photosensitivity, and the address aad.org/public/diseases/a-z/photosensitivity returns HTTP 404. The quotations below come from the sun allergy section of this general summer skin page, which is written about allergic sun reactions rather than about photosensitivity as a whole. Quoted from the page’s own text: “Check your medication container (or ask your pharmacist) to find out if it can cause an allergic reaction when you go out in the sun.”; “Medications that can cause an allergic sun reaction include ketoprofen (found in some pain meds) and these antibiotics”; “If the medicine can cause a reaction, stay out of the sun.”; “Protect your skin from the sun. You can do this by seeking shade, wearing sun-protective clothes, and applying sunscreen that offers broad-spectrum protection, water resistance, and an SPF of 30 or more.” The antibiotics sentence continues after a dash with the three names tetracycline, doxycycline and minocycline; we quoted the sentence up to that dash and attributed the three names outside the quotation marks rather than altering the sentence. link

FDA-approved labeling, read on DailyMed on 2026-07-29:
[4] Doxycycline hyclate delayed-release tablet, Actavis Pharma, Inc. DailyMed set id c2b08332-3256-4658-965a-ede3d973a388. Quoted from the Patient Counseling Information section of that one label, in full so that nothing is hidden by our cropping: “to avoid excessive sunlight or artificial ultraviolet light while receiving doxycycline and to discontinue therapy if phototoxicity (for example, skin eruptions, etc.) occurs. Sunscreen or sunblock should be considered [see Warnings and Precautions (5.3)].” In the article we quoted only the sunlight clause and the sunscreen sentence, and said so in the text; the clause about therapy is written for a prescriber to discuss with a patient and we did not restate it as advice. Also quoted from the Photosensitivity subsection of the Warnings and Precautions of the same label: “Photosensitivity manifested by an exaggerated sunburn reaction has been observed in some individuals taking tetracyclines.” The Highlights section of the same label carries the line “Limit sun exposure.” Scope, and it matters here: everything above describes this one label and no other. Doxycycline is sold by many manufacturers, their labels are written in more than one format, and the section headings and numbering are not the same across them, which is why we have named the sections rather than cited section numbers. Counting method, since the number depends on it: we queried DailyMed’s own listing service by drug name on 29 July 2026, which returned 385 records for doxycycline. A free-text search on the DailyMed website on the same day returned 385 as well. link
[5] Hydrochlorothiazide capsule, REMEDYREPACK INC. DailyMed set id 0789baef-3424-43ab-a3fb-4908172da565. Photosensitivity appears in the Adverse Reactions section under Hypersensitivity, in this list: “Anaphylactic reactions, necrotizing angiitis (vasculitis and cutaneous vasculitis), respiratory distress including pneumonitis and pulmonary edema, photosensitivity, fever, urticaria, rash, purpura.” Searching the full text of that one label for “sunscreen” and for “sun protection” returned no matches. Scope, stated as narrowly as we can: this describes the single label named above and nothing else. Hydrochlorothiazide is sold by many manufacturers and repackagers, their labels differ in wording, and querying DailyMed’s listing service by drug name on 29 July 2026 returned 789 records for hydrochlorothiazide, of which we opened one. That figure moves with the counting method: a free-text search on the DailyMed website the same day returned 795. We did not work out what accounts for the difference of six, and we are reporting both numbers rather than picking the one we like. The figure used in our text is the drug-name query, 789. The absence of sun protection wording on that one label is not evidence about the risk of the drug, and it is not a claim about any other label. link

A note on what this page is: an editorial guide about sun protection, written by a sunscreen site. It isn’t medical advice, it can’t see your skin or your chart, and it contains no recommendation about any prescription. For anything to do with the medication itself, your prescriber and your pharmacist are the people with standing.

Topics: · · All topics

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *